FMT for Postop Crohn's Disease

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

December 25, 2023

Study Completion Date

December 1, 2025

Conditions
Crohn Disease
Interventions
BIOLOGICAL

Capsule fecal microbiota material (cap-FMT)

Cap-FMT consists of Lyophilized FMT administered at 5 x 10\^11 bacteria per capsule daily for five days, for a total dose of 2.5 x 10\^12 bacteria.

BIOLOGICAL

Colonoscopic fecal microbiota material (colo-FMT)

Colo-FMT consists of rehydrated Lyophilized FMT material administered as a single dose of 2.5 x 10\^12 bacteria as liquid.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER